TECH
Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
$51.95
-2.92% today
Updated 2026-04-29
Market cap
$8.13B
P/E ratio
98.02
P/S ratio
6.69x
EPS (TTM)
$0.53
Dividend yield
0.60%
52W range
$46 – $72
Volume
2.2M
Bio-Techne Corp (TECH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
6.67%
Operating margin
19.70%
ROE
3.97%
ROA
6.52%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $202.62M | $73.35M | 77.44% | 53.55% | 36.20% |
| 2007 | $223.48M | $85.11M | 79.12% | 55.55% | 38.08% |
| 2008 | $257.42M | $103.56M | 79.45% | 56.05% | 40.23% |
| 2009 | $263.96M | $105.24M | 78.98% | 57.12% | 39.87% |
| 2010 | $269.05M | $109.78M | 79.76% | 58.10% | 40.80% |
| 2011 | $289.96M | $112.30M | 77.57% | 56.23% | 38.73% |
| 2012 | $314.56M | $112.33M | 74.96% | 52.84% | 35.71% |
| 2013 | $310.57M | $112.56M | 74.41% | 51.02% | 36.24% |
| 2014 | $357.76M | $110.95M | 70.27% | 44.65% | 31.01% |
| 2015 | $452.25M | $107.73M | 67.94% | 32.51% | 23.82% |
| 2016 | $499.02M | $104.48M | 67.46% | 30.18% | 20.94% |
| 2017 | $563.00M | $77.29M | 66.53% | 21.63% | 13.73% |
| 2018 | $642.99M | $125.35M | 67.21% | 21.18% | 19.49% |
| 2019 | $714.01M | $96.07M | 66.31% | 17.59% | 13.46% |
| 2020 | $738.69M | $229.30M | 65.41% | 21.31% | 31.04% |
| 2021 | $931.03M | $140.41M | 67.97% | 25.49% | 15.08% |
| 2022 | $1.11B | $272.05M | 68.42% | 26.83% | 24.61% |
| 2023 | $1.14B | $285.26M | 67.72% | 26.30% | 25.10% |
| 2024 | $1.16B | $168.10M | 66.41% | 17.83% | 14.50% |
| 2025 | $1.22B | $73.40M | 64.80% | 8.38% | 6.02% |